<DOC>
	<DOCNO>NCT00651729</DOCNO>
	<brief_summary>The purpose study evaluate safety repeat dos Botulinum Toxin Type A treatment focal upper limb poststroke spasticity</brief_summary>
	<brief_title>Safety Study Botulinum Toxin Type A Treatment Focal Upper Limb Poststroke Spasticity</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Medically stable poststroke patient spastic muscle upper limb Stroke within 6 month study enrollment Previous therapy Botulinum Toxin Type A treatment condition prior 4 month enrollment , treatment condition prior 01 January 1998</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>